WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹907 Cr | ₹760 Cr | ₹626 Cr | ₹527 Cr | ₹489 Cr |
What is the latest Total Liabilities ratio of WINDLAS BIOTECH ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹907 Cr |
| Mar2025 | ₹760 Cr |
| Mar2024 | ₹626 Cr |
| Mar2023 | ₹527 Cr |
| Mar2022 | ₹489 Cr |
How is Total Liabilities of WINDLAS BIOTECH Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹907 Cr | 19.30 | |
| Mar2025 | ₹760 Cr | 21.50 | |
| Mar2024 | ₹626 Cr | 18.73 | |
| Mar2023 | ₹527 Cr | 7.77 | |
| Mar2022 | ₹489 Cr | - | |
Compare Total Liabilities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹2,060.3 Cr | 0.8% | 16.8% | -2.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | 0.8% |
16.8% |
-2.9% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses